Target intelligence / Profile preview

Pro-inflammatory signaling

Molecular classification
Other
01

Overview

Pro-inflammatory signaling refers to the complex network of biochemical pathways that initiate and sustain the inflammatory response in biological systems [1]. This process is typically triggered by the recognition of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) by pattern recognition receptors, leading to the activation of key transcription factors such as NF-kappaB and the subsequent release of cytokines like TNF-alpha, IL-1, and IL-6 [2]. While these signals are essential for host defense and tissue repair, their chronic or dysregulated activation is a primary driver of tissue damage in numerous conditions, including rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis [3]. Therapeutic strategies generally focus on specific nodes within these pathways, such as cytokine neutralization or kinase inhibition, to restore immune homeostasis [4]. Because 'pro-inflammatory signaling' encompasses a vast array of distinct molecular targets rather than a single protein, it is classified as a biological process or pathway rather than a discrete therapeutic target [1, 2].

Other names
Inflammatory signaling pathwayPro-inflammatory cascadeCytokine signalingInnate immune signaling
02

Mechanism of action

Modulation of inflammatory cascades through the neutralization of specific cytokines, antagonism of their respective receptors, or inhibition of intracellular kinases (e.g., JAKs) and transcription factors (e.g., NF-kappaB) involved in signal transduction.

03

Biological functions

Signal transductionImmune responseApoptosisCell proliferationCell death
04

Disease associations

InflammationAutoimmune diseaseCancerCardiovascular diseaseNeurodegenerative diseaseInfection
05

Safety considerations

Increased risk of serious bacterial, viral, and fungal infectionsReactivation of latent tuberculosisPotential increased risk of certain malignancies (e.g., lymphoma)Injection site or infusion-related reactionsCytopenias
06

Interacting drugs

7 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Erythrocyte sedimentation rate (ESR)Procalcitonin

Beyond the preview

Go deeper on Pro-inflammatory signaling.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro-inflammatory signaling.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call